E. Schacht - Concepedia

Author

E. Schacht

Klinikum Leverkusen

Also Known As

E Schacht, E Von Schacht, E. Schacht, ERICH SCHACHT, Erich Schacht

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Klinikum Leverkusen University of Cologne Universitätsklinik Balgrist Klinikum Esslingen Kantonsspital Baselland

About

E. Schacht is an author at Klinikum Leverkusen specializing in medicine, osteoporosis, and bone health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	710
2	Health Sciences	7	7	275
3	Applied Physiology	3	3	141
4	Endocrinology	3	3	86
5	Clinical Nutrition	1	1	28

E. Schacht

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Alfacalcidol Reduces the Number of Fallers in a Community‐Dwelling Elderly Population with a Minimum Calcium Intake of More Than 500 Mg Daily Laurent Dukas, H. Bischoff, Lyn S. Lindpaintner, Journal of the American Geriatrics Society	2004	181
In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures Laurent Dukas, E. Schacht, H.B. Stähelin Osteoporosis International Elderly MenBone DiseaseBone HealthLow Creatinine ClearanceRisk Factor	2005	114
Treatment of Glucocorticoid-Induced Osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium J. D. Ringe, A. Cöster, E. Schacht, Calcified Tissue International Bone DiseaseBone HealthGlucocorticoid-induced OsteoporosisMedicineOsteoporosis	1999	79
A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65�ml/min Laurent Dukas, E. Schacht, Z. Mazor, Osteoporosis International Fall PreventionElderly MenPhysical ActivityGeriatricsLow Creatinine Clearance	2004	78
Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial) J. D. Ringe, P. Farahmand, E. Schacht, Rheumatology International Bone DiseaseBone HealthMale OsteoporosisOrthopaedicsVitamin D	2007	67
Better functional mobility in community-dwelling elderly is related to D-hormone serum levels and to daily calcium intake. Laurent Dukas, Hannes B. Staehelin, E. Schacht, PubMed	2006	61
Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of <65�ml/min Laurent Dukas, E. Schacht, Z. Mazor, Osteoporosis International Fall PreventionElderly PeopleLow Creatinine ClearanceGeriatric Fracture CarePharmacotherapy	2004	53
Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis E. Schacht, J. D. Ringe, A. Dorst, Rheumatology International Bone DiseaseBone HealthPlain Vitamin DGlucocorticoid-induced OsteoporosisPharmacology	2004	53
Multifactorial pathogenesis of falls as a basis for multifactorial interventions. Martin Runge, E. Schacht PubMed Fall PreventionKinesiologyHealth SciencesPost-surgical RecoveryInterdisciplinary Teams	2005	53
The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. E. Schacht, Florent Richy, Jean‐Yves Reginster PubMed Muscle MetabolismTherapeutic EffectsOsteoporosisOrthopaedic SurgeryBone Disease	2006	43

Page 1